首页> 美国卫生研究院文献>Arthroplasty Today >Aspirin used for venous thromboembolism prophylaxis in total hip arthroplasty decreases heterotopic ossification
【2h】

Aspirin used for venous thromboembolism prophylaxis in total hip arthroplasty decreases heterotopic ossification

机译:在总髋关节置换术中用于静脉血栓栓塞术预防的阿司匹林降低了异位骨化

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Heterotopic ossification (HO) is a known complication of total hip arthroplasty (THA) that can lead to persistent pain, stiffness, nerve impingement, and instability. Aspirin (ASA) has become an increasingly popular method of venous thromboembolism (VTE) prophylaxis, given its availability, ease of use, and relative safety. Although indomethacin has been commonly used for HO prophylaxis, we wanted to determine whether ASA, given the similar mechanism of action, may be effective in reducing the risk of HO in routine unilateral, primary THA when already being used for VTE prophylaxis.
机译:异位骨化(HO)是全髋关节置换术(THA)的已知并发症,其可导致持续的疼痛,刚度,神经冲击和不稳定性。鉴于其可用性,易用性和相对安全性,阿司匹林(ASA)已成为常静脉血栓栓塞(VTE)预防的静脉血栓栓塞(VTE)方法。虽然吲哚美辛常用于HO预防,但我们想确定鉴于类似机制的ASA,可能有效降低常规单侧,初级THA在vte预防的常规初级母素的风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号